title: Relief of cyclin A gene transcriptional inhibition during activation of human primary T lymphocytes via CD2 and CD28 adhesion molecules.
abstract: Cyclin A transcription is cell cycle regulated and induced by cell proliferative signals. To understand the mechanisms underlined in this regulation in normal human cells, we have analysed in vivo protein-DNA interactions at the Cyclin A locus in primary T lymphocytes. Stimulation of purified T lymphocytes by a combination of monoclonal antibodies directed at CD2 and CD28 adhesion molecules gives rise to a long lasting proliferation in the absence of accessory cells. Cyclin A was observed after 4 days of costimulation with anti CD2 + CD28 whereas stimulation by anti CD2 or anti CD28 alone was not effective. In vivo genomic DMS footprinting revealed upstream of the major transcription initiation sites, the presence of at least three protein binding sites, two of which were constitutively occupied. They bind in vitro respectively ATF-1 and NF-Y proteins. The third site was occupied in quiescent cells or in cells stimulated by anti CD2 or anti CD28 alone. The mitogenic combination of anti CD2 + anti CD28 released the footprint as cells were committed to proliferation. Consistent with theses results, nuclear extracts prepared from quiescent cells formed a specific complex with this element, whereas extracts prepared from cells treated with anti CD2 + anti CD28 failed to do so after cells entered a proliferative state.
authors.affiliation: Institut de Génétique Moléculaire de Montpellier, CNRS, UMR 5535, France.
authors.forename: A
authors.initials: A
authors.lastname: Plet
authors.forename: X
authors.initials: X
authors.lastname: Huet
authors.forename: M
authors.initials: M
authors.lastname: Algarté
authors.forename: J
authors.initials: J
authors.lastname: Rech
authors.forename: J
authors.initials: J
authors.lastname: Imbert
authors.forename: A
authors.initials: A
authors.lastname: Philips
authors.forename: J M
authors.initials: JM
authors.lastname: Blanchard
mesh_terms: D051697:Activating Transcription Factor 1; D000911:Antibodies, Monoclonal; D001665:Binding Sites; D022762:CCAAT-Enhancer-Binding Proteins; D018801:CD2 Antigens / Q000502:physiology*; D018106:CD28 Antigens / Q000502:physiology*; D002453:Cell Cycle / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D002478:Cells, Cultured; D016213:Cyclins / Q000235:genetics* / Q000378:metabolism; D018983:DNA Footprinting; D004268:DNA-Binding Proteins / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D008213:Lymphocyte Activation; D015375:Receptors, Interleukin-2 / Q000235:genetics / Q000378:metabolism; D013601:T-Lymphocytes / Q000378:metabolism / Q000502:physiology*; D013997:Time Factors; D014157:Transcription Factors / Q000378:metabolism
chemical_list: D051697:Activating Transcription Factor 1; D000911:Antibodies, Monoclonal; D022762:CCAAT-Enhancer-Binding Proteins; D018801:CD2 Antigens; D018106:CD28 Antigens; D016213:Cyclins; D004268:DNA-Binding Proteins; D015375:Receptors, Interleukin-2; D014157:Transcription Factors